Patent details

Basic Information

Publication number:

EP3513804

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP182111567

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FACTOR VIII CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF

French Title of Invention:

POLYPEPTIDES CHIMÉRIQUES ET HYBRIDES DE FACTEUR VIII ET LEURS PROCÉDÉS D'UTILISATION

German Title of Invention:

CHIMÄRE UND HYBRIDE FAKTOR-VIII-POLYPEPTIDE UND VERFAHREN ZUR VERWENDUNG DAVON

SPC Number:

Dates

Filing date:

06/07/2012

Grant date:

23/03/2022

EP Publication Date:

24/07/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/03/2022

EP B1 Publication Date:

23/03/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

06/07/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/03/2022

 

 

Name:

Bioverativ Therapeutics Inc.

Address:

225 Second Avenue, Waltham MA 02451, United States (US)

Agent

Name:

ARONOVA S.A.

From:

06/05/2022

Address:

PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

PETERS, Robert

Address:

United States (US)

2

Name:

MCKINNEY, Byron

Address:

United States (US)

3

Name:

LUK, Alvin

Address:

United States (US)

4

Name:

LI, Lian

Address:

United States (US)

5

Name:

JIANG, Haiyan

Address:

United States (US)

6

Name:

BITONTI, Alan, J.

Address:

United States (US)

7

Name:

LOW, Susan

Address:

United States (US)

8

Name:

PIERCE, Glenn

Address:

United States (US)

9

Name:

DUMONT, Jennifer A.

Address:

United States (US)

10

Name:

NUGENT, Karen

Address:

United Kingdom (GB)

11

Name:

OTTMER, Matt

Address:

United States (US)

12

Name:

SOMMER, Jurg

Address:

United States (US)

Priority

1

Priority Number:

201161506015 P

Priority Date:

08/07/2011

Priority Country:

United States (US)

2

Priority Number:

201161522647 P

Priority Date:

11/08/2011

Priority Country:

United States (US)

3

Priority Number:

201161541561 P

Priority Date:

30/09/2011

Priority Country:

United States (US)

4

Priority Number:

201161569158 P

Priority Date:

09/12/2011

Priority Country:

United States (US)

5

Priority Number:

201261586443 P

Priority Date:

13/01/2012

Priority Country:

United States (US)

6

Priority Number:

201261622789 P

Priority Date:

11/04/2012

Priority Country:

United States (US)

7

Priority Number:

201261657641 P

Priority Date:

08/06/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/37; C07K 14/755; A61K 47/60; A61K 47/68; G01N 33/86; A61P 7/02; A61P 43/00;

Publication

European Patent Bulletin

1

Issue number:

202212

Publication date:

23/03/2022

Description:

Grant (B1)

2

Issue number:

202218

Publication date:

04/05/2022

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

31/07/2025

Annual Fee Number:

14

Annual Fee Amount:

198 Euro

Expected Payer:

Last Annual Fee Payment Date:

26/06/2024

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
06/05/2022	Power Of Attorney	1
06/05/2022	Outgoing Correspondence	1